D
Don J. Mahuran
Researcher at University of Toronto
Publications - 111
Citations - 4919
Don J. Mahuran is an academic researcher from University of Toronto. The author has contributed to research in topics: Hexosaminidase & Mutant. The author has an hindex of 36, co-authored 111 publications receiving 4601 citations. Previous affiliations of Don J. Mahuran include McMaster University & Ontario Veterinary College.
Papers
More filters
Journal ArticleDOI
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.
Dapeng Zhou,Carlos Cantu,Yuval Sagiv,Nicolas Schrantz,Ashok B. Kulkarni,Xiaoyang Qi,Don J. Mahuran,Carlos R. Morales,Gregory A. Grabowski,Kamel Benlagha,Paul B. Savage,Albert Bendelac,Luc Teyton +12 more
TL;DR: Mice deficient in prosaposin, the precursor to a family of endosomal lipid transfer proteins (LTP), exhibit specific defects in CD1d-mediated antigen presentation and lack Vα14 NKT cells, which constitute a previously unknown link between lipid metabolism and immunity.
Journal ArticleDOI
Presenilin-1, Nicastrin, Amyloid Precursor Protein, and γ-Secretase Activity Are Co-localized in the Lysosomal Membrane
Stephen H. Pasternak,Richard D. Bagshaw,Marianne Guiral,Sunqu Zhang,Cameron Ackerley,Brian J. Pak,John W. Callahan,Don J. Mahuran +7 more
TL;DR: It is shown that significant amounts of mature nicastrin, presenilin-1, and APP are co-localized with lysosomal associated membrane protein-1 (cAMP-1) in the outer membranes of lYSosomes and that γ-secretase is a lysOSomal protease.
Journal ArticleDOI
Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
Gustavo Maegawa,Michael B. Tropak,Justin D. Buttner,Brigitte Rigat,Maria Fuller,Deepangi Pandit,Liangiie Tang,G. Kornhaber,Yoshitomo Hamuro,Joe T.R. Clarke,Don J. Mahuran +10 more
TL;DR: Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase, and modeling studies indicated that ABX interacts with both active and non-active site residues.
Journal ArticleDOI
Crystal Structure of Human β-Hexosaminidase B: Understanding the Molecular Basis of Sandhoff and Tay-Sachs Disease
TL;DR: In this article, the crystal structure of human Hex B, alone and in complex with the mechanistic inhibitors GalNAc-isofagomine (2.4A) and NAG-thiazoline(2.5A) was presented.
Journal ArticleDOI
Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients
TL;DR: It is proposed that hexosaminidase inhibitors function as pharmacological chaperones, enhancing the stability of the native conformation of the enzyme, increasing the amount of hexosaminaidase A capable of exiting the endoplasmic reticulum for transport to the lysosome, and could provide a novel approach to the treatment of adult Tay-Sachs and possibly Sandhoff diseases.